GR3005204T3 - - Google Patents

Info

Publication number
GR3005204T3
GR3005204T3 GR920401453T GR920401453T GR3005204T3 GR 3005204 T3 GR3005204 T3 GR 3005204T3 GR 920401453 T GR920401453 T GR 920401453T GR 920401453 T GR920401453 T GR 920401453T GR 3005204 T3 GR3005204 T3 GR 3005204T3
Authority
GR
Greece
Application number
GR920401453T
Other languages
Greek (el)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of GR3005204T3 publication Critical patent/GR3005204T3/el

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/26Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GR920401453T 1986-03-31 1992-07-16 GR3005204T3 (https=)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/846,541 US4769378A (en) 1986-03-31 1986-03-31 Indenopyrimidine aromatase inhibitors

Publications (1)

Publication Number Publication Date
GR3005204T3 true GR3005204T3 (https=) 1993-05-24

Family

ID=25298228

Family Applications (1)

Application Number Title Priority Date Filing Date
GR920401453T GR3005204T3 (https=) 1986-03-31 1992-07-16

Country Status (21)

Country Link
US (1) US4769378A (https=)
EP (1) EP0240263B1 (https=)
JP (1) JPH0751568B2 (https=)
KR (1) KR890003838B1 (https=)
CN (1) CN1013673B (https=)
AR (1) AR245109A1 (https=)
AT (1) ATE78251T1 (https=)
AU (1) AU581809B2 (https=)
CA (1) CA1265140A (https=)
DE (1) DE3780338T2 (https=)
DK (1) DK165245C (https=)
ES (1) ES2042552T3 (https=)
GR (1) GR3005204T3 (https=)
HU (1) HU196379B (https=)
IE (1) IE59762B1 (https=)
IL (1) IL81978A (https=)
NZ (1) NZ219748A (https=)
PH (1) PH23398A (https=)
PT (1) PT84553B (https=)
SU (1) SU1470185A3 (https=)
ZA (1) ZA872162B (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5780465A (en) * 1997-04-03 1998-07-14 Dow Agrosciences Llc 4-substituted 5-polycyclylpyrimidine herbicides
SE0401790D0 (sv) * 2004-07-07 2004-07-07 Forskarpatent I Syd Ab Tamoxifen response in pre- and postmenopausal breast cancer patients
US7982035B2 (en) 2007-08-27 2011-07-19 Duquesne University Of The Holy Spirit Tricyclic compounds having antimitotic and/or antitumor activity and methods of use thereof
US7960400B2 (en) 2007-08-27 2011-06-14 Duquesne University Of The Holy Ghost Tricyclic compounds having cytostatic and/or cytotoxic activity and methods of use thereof
WO2009125299A2 (en) * 2008-03-05 2009-10-15 Lewis James D Quick-change fishing lure system and method of using
KR101560061B1 (ko) * 2012-11-30 2015-10-15 주식회사 엘지화학 신규한 화합물 및 이를 이용한 유기 전자 소자

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3133922A (en) * 1964-05-19 Z-cyano-
GB956269A (en) * 1960-04-01 1964-04-22 Manuf Prod Pharma Substituted indeno-pyrimidines
US3177216A (en) * 1961-12-28 1965-04-06 Searle & Co 4-trifluoromethyl-2-thio-5h-alka[d]-pyrimidines and congeners
US3763178A (en) * 1968-09-05 1973-10-02 American Home Prod Imidazolinyl phenyl carbonyl acid addition salts and related compounds
BE795636A (fr) * 1972-02-19 1973-08-20 Schering Ag Nitroimidazolylpyrimidines, et leur procede de preparation
US3925384A (en) * 1974-10-21 1975-12-09 Squibb & Sons Inc 2-Amino-4,5-dihydro-4-arylindeno pyrimidines
US4235893A (en) * 1978-05-08 1980-11-25 Brodie Angela M Ester derivatives of 4-hydroxy-4-androstene-3,17-dione and a method for inhibiting estrogen biosynthesis
NZ206968A (en) * 1983-02-02 1986-06-11 Lilly Co Eli Pyrimidine derivatives pharmaceutical formulations

Also Published As

Publication number Publication date
EP0240263B1 (en) 1992-07-15
IE59762B1 (en) 1994-03-23
KR870008857A (ko) 1987-10-21
DK161187A (da) 1987-10-01
PH23398A (en) 1989-07-26
CN87102424A (zh) 1987-10-07
HUT43834A (en) 1987-12-28
JPS62238275A (ja) 1987-10-19
AU581809B2 (en) 1989-03-02
EP0240263A3 (en) 1988-09-28
PT84553B (pt) 1989-11-10
CA1265140A (en) 1990-01-30
IL81978A (en) 1991-03-10
DK161187D0 (da) 1987-03-30
ZA872162B (en) 1988-10-26
DK165245B (da) 1992-10-26
AU7075287A (en) 1987-10-08
JPH0751568B2 (ja) 1995-06-05
CN1013673B (zh) 1991-08-28
DK165245C (da) 1993-03-22
DE3780338T2 (de) 1993-03-04
DE3780338D1 (de) 1992-08-20
US4769378A (en) 1988-09-06
IL81978A0 (en) 1987-10-20
HU196379B (en) 1988-11-28
NZ219748A (en) 1989-05-29
KR890003838B1 (ko) 1989-10-05
ES2042552T3 (es) 1993-12-16
EP0240263A2 (en) 1987-10-07
IE870812L (en) 1987-09-30
PT84553A (en) 1987-04-01
ATE78251T1 (de) 1992-08-15
SU1470185A3 (ru) 1989-03-30
AR245109A1 (es) 1993-12-30

Similar Documents

Publication Publication Date Title
IN165475B (https=)
AU7131891A (https=)
IN164558B (https=)
IN167977B (https=)
DE3790858T (https=)
IN168202B (https=)
IN170297B (https=)
GR3005204T3 (https=)
IN168441B (https=)
IN170635B (https=)
IN167929B (https=)
IN170756B (https=)
FR2609208B2 (https=)
AU6562586A (https=)
AU7131791A (https=)
AU6019186A (https=)
BE905391A (https=)
AU5783386A (https=)
AU5857886A (https=)
AU5878886A (https=)
BE905236A (https=)
BE905208A (https=)
AU5940986A (https=)
BE905135A (https=)
AU6014586A (https=)